Alec Witty
Fate Therapeutics (United States)(US)
Publications by Year
Research Areas
CAR-T cell therapy research, Congenital heart defects research, Tissue Engineering and Regenerative Medicine, CRISPR and Genetic Engineering, Pluripotent Stem Cells Research
Most-Cited Works
- → Stage-Specific Optimization of Activin/Nodal and BMP Signaling Promotes Cardiac Differentiation of Mouse and Human Pluripotent Stem Cell Lines(2011)1,171 cited
- → Generation of the epicardial lineage from human pluripotent stem cells(2014)202 cited
- → Cloche is a bHLH-PAS transcription factor that drives haemato-vascular specification(2016)175 cited
- → Parthenogenetic stem cells for tissue-engineered heart repair(2013)114 cited
- → Canonical Wnt5b Signaling Directs Outlying Nkx2.5+ Mesoderm into Pacemaker Cardiomyocytes(2019)94 cited
- → Dual antigen–targeted off-the-shelf NK cells show durable response and prevent antigen escape in lymphoma and leukemia(2022)79 cited
- → Quadruple gene-engineered natural killer cells enable multi-antigen targeting for durable antitumor activity against multiple myeloma(2022)71 cited
- → Cell-Surface Marker Signature for Enrichment of Ventricular Cardiomyocytes Derived from Human Embryonic Stem Cells(2018)57 cited
- → Functional arrays of human pluripotent stem cell-derived cardiac microtissues(2020)47 cited
- → FZD4 Marks Lateral Plate Mesoderm and Signals with NORRIN to Increase Cardiomyocyte Induction from Pluripotent Stem Cell-Derived Cardiac Progenitors(2017)32 cited